Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Ductus Arteriosus, Patent

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Ductus Arteriosus, Patent in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eguchi, H; Itakura, Y; Kamiya, K; Kaneko, K; Koyama, N; Ogawa, Y; Ohama, Y; Takasaki, J; Tanaka, T1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Ductus Arteriosus, Patent

ArticleYear
Increased platelet activating factor in the tracheal aspirates from neonates with patent ductus arteriosus.
    Clinica chimica acta; international journal of clinical chemistry, 1993, Apr-16, Volume: 215, Issue:1

    Topics: Ductus Arteriosus, Patent; Female; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Male; Platelet Activating Factor; Suction; Trachea

1993